Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia—a systematic review of the literature

RATIONALE: The licensed dose range for the long-acting injectable antipsychotic flupentixol decanoate (Depixol®) in the treatment of schizophrenia is very broad. This provides little useful direction to prescribers and may ultimately result in patients receiving unnecessarily high doses. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailey, Loren, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828621/
https://www.ncbi.nlm.nih.gov/pubmed/31300829
http://dx.doi.org/10.1007/s00213-019-05311-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828621/
https://www.ncbi.nlm.nih.gov/pubmed/31300829
http://dx.doi.org/10.1007/s00213-019-05311-2

Ejemplares similares